Skip to content

A longitudinal study of cognitive impairment in patients with breast cancer

A longitudinal study of cognitive impairment in patients with breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100049781
Enrollment
Unknown
Registered
2021-08-09
Start date
2021-08-08
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Group 1:None
Group 2:None

Sponsors

Shandong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patient group: female, 18-65 years old, diagnosed with breast cancer for the first time and planning to receive treatment, able to complete the survey in Chinese reading, writing and comprehension; 2. Control group: female, 18-65 years old, not suffering from malignant tumor or mental illness, able to complete the survey on Chinese reading, writing and comprehension.

Exclusion criteria

Exclusion criteria: 1. Patient group: severe central nervous system disease, malignant tumor in other parts, received anticancer treatment (chemotherapy, radiotherapy, etc.), mental illness, severe brain injury, pregnancy or breastfeeding, received general anesthesia in the past 1 month; 2. Control group: Severe central nervous system disease, received anticancer therapy (chemotherapy, radiotherapy, etc.), severe brain injury, pregnant or breastfeeding, and received general anesthesia for the past 1 month.

Design outcomes

Primary

MeasureTime frame
Cognitive Function;

Secondary

MeasureTime frame
psychological status (e.g., anxiety, depression);clinical characteristics;

Countries

China

Contacts

Public ContactLi Jie

Shandong University

lijie2@126.com+86 531 88381567

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026